The weekly litigation news digest is live. Subscribe now

IP Verse

Ret Inhibitor For Use In Treating Cancer Having A Ret Alteration - EP3773589

The patent EP3773589 was granted to Blueprint Medicines on Nov 1, 2023. The application was filed on Apr 3, 2019 under application number EP19718531A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3773589

BLUEPRINT MEDICINES
Application Number
EP19718531A
Filing Date
Apr 3, 2019
Status
Granted And Under Opposition
Sep 29, 2023
Publication Date
Nov 1, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
SANDOZJul 12, 2024ELKINGTON AND FIFEADMISSIBLE

Patent Citations (19) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS19830627416
DESCRIPTIONUS19840626522
DESCRIPTIONUS19970626562
DESCRIPTIONUS20050626576
DESCRIPTIONCN105255927
DESCRIPTIONEP3037547
DESCRIPTIONJP2015109806
DESCRIPTIONUS2014272951
DESCRIPTIONUS2015057335
DESCRIPTIONUS2015177246
DESCRIPTIONUS9216172
DESCRIPTIONUS9297011
DESCRIPTIONWO2017079140
INTERNATIONAL-SEARCH-REPORTWO2017079140
INTERNATIONAL-SEARCH-REPORTWO2018071447
INTERNATIONAL-SEARCH-REPORTWO2018213329
OPPOSITIONWO2017079140
OPPOSITIONWO2018071447
OPPOSITIONWO2018213329

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents